Mortality in older patients admitted to an ICU for COVID-19: A systematic review.


Journal

Acta anaesthesiologica Scandinavica
ISSN: 1399-6576
Titre abrégé: Acta Anaesthesiol Scand
Pays: England
ID NLM: 0370270

Informations de publication

Date de publication:
10 2023
Historique:
revised: 06 05 2023
received: 10 03 2023
accepted: 02 06 2023
medline: 25 9 2023
pubmed: 16 6 2023
entrez: 16 6 2023
Statut: ppublish

Résumé

The objective was to conduct a systematic review of mortality and factors independently associated with mortality of older patients admitted to an intensive care unit (ICU) for COVID-19. Data sources were MEDLINE, EMBASE, the Cochrane Library, and references of included studies. Two reviewers independently selected studies evaluating mortality of older patients (≥ 70 years) admitted to an ICU for COVID-19. They extracted general characteristics, mortality rate, and factors independently associated with mortality. The methodological quality of each study was evaluated by using the Critical Appraisal Skills Programme checklist. We selected 36 studies (11,989 patients). Many of the studies were conducted in Europe (42%) and many were retrospective (61%) and multicenter (61%). ICU mortality ranged from 8% to 90%, 1-month mortality from 33% to 90% and 3-month mortality, reported in five studies, from 46% to 60%. Frailty, assessed by the Clinical Frailty Score (CFS), was significantly associated with 1-month and 3-month mortality respectively in two studies (hazard ratio [HR]: 3.2 [2.56-4.13] and HR: 2.83 [95% CI: 1.96-4.08]). In this systematic review of older patients admitted to an ICU with COVID-19, we documented high heterogeneity of mortality rates.

Identifiants

pubmed: 37323022
doi: 10.1111/aas.14299
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1140-1147

Informations de copyright

© 2023 Acta Anaesthesiologica Scandinavica Foundation.

Références

Coronavirus COVID-19 (2019-nCoV) [Internet]. September 22, 2021. Available from: https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782-793.
Zhou Y, Yang Q, Chi J, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis. Int J Infect Dis. 2020;99:47-56.
Zanella A, Florio G, Antonelli M, et al. Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units. Intensive Care Med. 2021;47:995-1008.
Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia. 2020;75:1340-1349.
Chew MS, Kattainen S, Haase N, et al. A descriptive study of the surge response and outcomes of ICU patients with COVID-19 during first wave in Nordic countries. Acta Anaesthesiol Scand. 2022;66:56-64.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752-762.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37-43.
Vallet H, Schwarz GL, Flaatten H, de Lange DW, Guidet B, Dechartres A. Mortality of older patients admitted to an ICU: a systematic review. Crit Care Med. 2021;49:324-334.
Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health. 2021;6:e006434.
Taylor EH, Marson EJ, Elhadi M, et al. Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis. Anaesthesia. 2021;76:1224-1232.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
Jung C, Fjølner J, Bruno RR, et al. Differences in mortality in critically ill elderly patients during the second COVID-19 surge in Europe. Crit Care. 2021;25:344.
Zerah L, Baudouin É, Pépin M, et al. Clinical characteristics and outcomes of 821 older patients with SARS-Cov-2 infection admitted to acute care geriatric wards. J Gerontol A Biol Sci Med Sci. 2021;76:e4-e12.
Lidou-Renault V, Baudouin E, Courtois-Amiot P, et al. Corticosteroid therapy in COVID-19 associated with in-hospital mortality in geriatric patients: a propensity matched cohort study. J Gerontol Ser A. 2022;77:1352-1360.
Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-710.
Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. Jama. 1993;270:2957-2963.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489-495.
Domecq JP, Lal A, Sheldrick CR, et al. Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry. Crit Care Med. 2021;49:437-448.
Dres M, Hajage D, Lebbah S, et al. Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : prognosis of COVID-19 elderly critically ill patients in the ICU. Ann Intensive Care. 2021;11:77.
Cardona M, Dobler CC, Koreshe E, et al. A catalogue of tools and variables from crisis and routine care to support decision-making about allocation of intensive care beds and ventilator treatment during pandemics: scoping review. J Crit Care. 2021;66:33-43.
Alban A, Chick SE, Dongelmans DA, Vlaar APJ, Sent D. ICU capacity management during the COVID-19 pandemic using a process simulation. Intensive Care Med. 2020;46:1624-1626.
Aziz S, Arabi YM, Alhazzani W, et al. Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med. 2020;46:1-23.
Winkelmann J, Webb E, Williams GA, Hernández-Quevedo C, Maier CB, Panteli D. European countries' responses in ensuring sufficient physical infrastructure and workforce capacity during the first COVID-19 wave. Health Policy. 2022;126:362-372.
Trentini F, Marziano V, Guzzetta G, et al. Pressure on the health-care system and intensive care utilization during the COVID-19 outbreak in the Lombardy region of Italy: a retrospective observational study in 43,538 hospitalized patients. Am J Epidemiol. 2022;191:137-146.
Aquino YSJ, Rogers WA, Scully JL, Magrabi F, Carter SM. Ethical guidance for hard decisions: a critical review of early international COVID-19 ICU triage guidelines. Health Care Anal. 2022;30:163-195.
Karagiannidis C, Hentschker C, Westhoff M, et al. Observational study of changes in utilization and outcomes in mechanical ventilation in COVID-19. PloS One. 2022;17:e0262315.
Rama-Maceiras P, Sanduende Y, Taboada M, et al. Critical patients COVID-19 has changed the management and outcomes in the ICU after 1 year of the pandemic?A multicenter, prospective, observational study. Enferm Infecc Microbiol Clin. 2023;41:70-78.
Carbonell R, Urgelés S, Rodríguez A, et al. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: a multicentre retrospective cohort study. Lancet Reg Health Eur. 2021;11:100243.
Zirpe KG, Dixit S, Kulkarni A, et al. The second-vs first-wave COVID-19: more of the same or a lot worse? A comparison of mortality between the two waves in patients admitted to intensive care units in nine hospitals in Western Maharashtra. Indian J Crit Care Med. 2021;25:1343-1348.
Jung C, Wernly B, Fjølner J, et al. Steroid use in elderly critically ill COVID-19 patients. Eur Respir J. 2021;58:2100979.
Cook TM, Roberts JV. Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19. Anaesthesia. 2021;76:608-616.
Hewitt J, Carter B, Vilches-Moraga A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5:e444-e451.
Covino M, Russo A, Salini S, et al. Frailty assessment in the emergency department for risk stratification of COVID-19 patients aged ≥80 years. J Am Med Dir Assoc. 2021;22:1845-1852.e1.
NICE. NICE updates rapid COVID-19 guideline on critical care | News and features | News [Internet]. January 26, 2022. https://www.nice.org.uk/news/article/nice-updates-rapid-covid-19-guideline-on-critical-care

Auteurs

Céline Bianco (C)

Department of Geriatrics, Saint Antoine Hospital, APHP, Paris, France.

Bertrand Guidet (B)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Service de Réanimation Médicale, Hôpital Saint-Antoine, AP-HP, Paris, France.

Hans Flaatten (H)

Department of Clinical Medicine, University of Bergen, Department of Research and Development, Haukeland University Hospital, Bergen, Norway.

Agnès Dechartres (A)

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP. Sorbonne Université, Hôpital Pitié Salpêtrière, Département de Santé Publique, Paris, France.

Hélène Vallet (H)

Sorbonne Université, INSERM, UMRS 1135, Centre d'immunologie et de Maladies Infectieuses (CIMI), Department of Geriatrics, Saint Antoine Hospital, APHP, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH